Literature DB >> 19130183

Lipid-activated transcription factors control bile acid glucuronidation.

Olivier Barbier1, Jocelyn Trottier, Jenny Kaeding, Patrick Caron, Mélanie Verreault.   

Abstract

Bile acids subserve important physiological functions in the control of cholesterol homeostasis. Indeed, hepatic bile acid synthesis and biliary excretion constitute the main route for cholesterol removal from the human body. On the other hand, bile acids serve as natural detergents for the intestinal absorption of dietary cholesterol. However, due to their detergent properties, bile acids are inherently cytotoxic, and their cellular level may be tightly controlled to avoid pathological situations such as cholestasis. Recent investigations have illustrated the crucial roles that a series of ligand-activated transcription factors has in the control of hepatic bile acids synthesis, transport and metabolism. Thus, the lipid-activated nuclear receptors, farnesoid X-receptor (FXR), liver X-receptor (LXR), pregnane X-receptor (PXR) and peroxisome proliferator-activated receptor alpha (PPAR alpha), modulate the expression and activity of genes controlling bile acid homeostasis in the liver. Several members of the UDP-glucuronosyltransferase (UGT) enzymes family are among the bile acid metabolizing enzymes regulated by these receptors. UGTs catalyze glucuronidation, a major phase II metabolic reaction, which converts hydrophobic bile acids into polar and urinary excretable metabolites. This article summarizes our recent observations on the regulation of bile acid conjugating UGTs upon pharmacological activation of lipid-activated receptors, with a particular interest for the role of PPAR alpha and LXRalpha in controlling human UGT1A3 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130183     DOI: 10.1007/s11010-008-0001-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.

Authors:  Jocelyn Trottier; Mélanie Verreault; Susan Grepper; Didier Monté; Julie Bélanger; Jenny Kaeding; Patrick Caron; Ted T Inaba; Olivier Barbier
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

Review 2.  Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.

Authors:  Jocelyn Trottier; Piotr Milkiewicz; Jenny Kaeding; Mélanie Verreault; Olivier Barbier
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

3.  Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation.

Authors:  Kathy Senekeo-Effenberger; Shujuan Chen; Erin Brace-Sinnokrak; Jessica A Bonzo; Mei-Fei Yueh; Upendra Argikar; Jenny Kaeding; Jocelyn Trottier; Rory P Remmel; Joseph K Ritter; Olivier Barbier; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2006-12-06       Impact factor: 3.922

4.  Novel pathways of bile acid metabolism involving CYP3A4.

Authors:  Karl Bodin; Ulla Lindbom; Ulf Diczfalusy
Journal:  Biochim Biophys Acta       Date:  2005-02-21

5.  The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis.

Authors:  M C Hunt; Y Z Yang; G Eggertsen; C M Carneheim; M Gåfvels; C Einarsson; S E Alexson
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

6.  Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.

Authors:  S M Post; H Duez; P P Gervois; B Staels; F Kuipers; H M Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

7.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.

Authors:  H U Marschall; H Matern; H Wietholtz; B Egestad; S Matern; J Sjövall
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Serum concentrations of glucuronidated and sulfated bile acids in children with cholestasis.

Authors:  H Takikawa; T Beppu; Y Seyama; K Obinata; H Nittono
Journal:  Biochem Med       Date:  1985-06

Review 9.  Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans.

Authors:  Alain Bélanger; Georges Pelletier; Fernand Labrie; Olivier Barbier; Sarah Chouinard
Journal:  Trends Endocrinol Metab       Date:  2003-12       Impact factor: 12.015

10.  The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice.

Authors:  Mélanie Verreault; Kathy Senekeo-Effenberger; Jocelyn Trottier; Jessica A Bonzo; Julie Bélanger; Jenny Kaeding; Bart Staels; Patrick Caron; Robert H Tukey; Olivier Barbier
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

View more
  21 in total

Review 1.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

2.  Social status affects lipid metabolism in rainbow trout, Oncorhynchus mykiss.

Authors:  Daniel J Kostyniuk; Brett M Culbert; Jan A Mennigen; Kathleen M Gilmour
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-21       Impact factor: 3.619

3.  The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver.

Authors:  Jocelyn Trottier; Diala El Husseini; Martin Perreault; Sophie Pâquet; Patrick Caron; Sylvie Bourassa; Mélanie Verreault; Ted T Inaba; Guy G Poirier; Alain Bélanger; Chantal Guillemette; Michael Trauner; Olivier Barbier
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

4.  PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.

Authors:  Cindy Yanfei Li; Joseph L Dempsey; Dongfang Wang; SooWan Lee; Kris M Weigel; Qiang Fei; Deepak Kumar Bhatt; Bhagwat Prasad; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2018-05-16       Impact factor: 3.922

5.  Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come.

Authors:  Nisanne S Ghonem; James L Boyer
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

Review 6.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

Review 7.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126

8.  Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate.

Authors:  J Trottier; P Caron; R J Straka; O Barbier
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

9.  Regulation of bile acid and cholesterol metabolism by PPARs.

Authors:  Tiangang Li; John Y L Chiang
Journal:  PPAR Res       Date:  2009-07-14       Impact factor: 4.964

10.  Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.

Authors:  Melissa Runge-Morris; Thomas A Kocarek
Journal:  PPAR Res       Date:  2009-08-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.